Today, the Infusion Access Foundation (IAF) released results from a new Morning Consult state-by-state survey of registered voters across six states, showing overwhelming and growing support for federal reforms of the 340B Drug Pricing Program.
The survey found that more than four in five voters (81% and above) across all six states are concerned about the cost of healthcare for themselves and their families. A significant majority of voters (over two-thirds) also reported that their healthcare costs have increased in recent years. These financial strains have led to serious consequences:
-Approximately half of all voters worry about affording basic living expenses because of healthcare costs.
– Around one in three voters have gone into debt as a result of medical expenses.
– Around one in three voters have used up all or most of their savings because of medical expenses.
Voters overwhelmingly agree that addressing rising healthcare and prescription drug costs should be an urgent priority for legislators. In every state surveyed, rising healthcare costs, high prescription drug costs, and high costs for urgent or emergency care were ranked among the top three most urgent problems for lawmakers to fix.
Despite its importance, public awareness of the 340B Drug Pricing Program is remarkably low, with only about one in five voters or less in each state having heard of it. However, after being presented with a neutral definition of the program, a majority of voters in all six states expressed support for it.
At the same time, this support for the program itself exists alongside a strong belief that it needs to be reformed. More than two-thirds of voters across all surveyed states believe that reforming 340B should be an urgent priority for lawmakers.
The survey tested various messages about the program, finding that roughly three out of four voters across all states found every statement about 340B to be compelling. The most compelling messages centered on the program’s lack of oversight, the role of Pharmacy Benefit Managers (PBMs) in pocketing discounts, and the failure of hospitals to pass savings directly to patients.
Understanding of the 340B program had a significant impact:
– The number of voters who said 340B reform was urgent increased by double-digit percentages in all six states.
– Over three-quarters of voters in every state indicated that they would be more likely to vote for a lawmaker who supports reforming the program after learning more about it.
From pharmacy benefit managers (PBMs) to coupon aggregators, the middlemen of the healthcare industry are reaping the benefits at the expense of patients.
Navigating the complexities of health insurance denials and prior authorization can feel like an endless game. As Kindyl Boyer, Infusion Access Foundation director of advocacy, aptly put it, some efforts to improve the system feel like playing “Whac-A-Mole.”
A recent CBS News article sheds light on the challenges patients face in accessing necessary care.
This article describes an active 80-year-old woman’s experience searching for monoclonal antibody drugs to treat her case of COVID-19. The interviewer lists our COVID-19 Antibody Therapy Locator as a tool that links those in need to infusion clinics offering antibody therapies. Note: This article has been syndicated to several local NPR branches’ websites.